On The Pen: The Weekly Dose

Send us a Text Message. Roche Pharmaceuticals has acquired Carmot Therapeutics along with three obesity and type 2 diabetes candidates: CT-868 / CT-368 / CT-986 MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Venmo: OnThePen Ca$h App: ManOnMounjaro Hello Fresh Free Box: https://www.hellofresh.com/pages/raf_lp11?c=FIH-XR3LF83PJ9QE&utm_campaign=referralinvite&utm_medium=clipboard&utm_source=freebies&utm_invitername=David&utm_term=web&discount_comm_id=992270dc-a684-4b10-bd34-da8bb5f811b2 SOCIAL LINKS https://www.tiktok.com/@manonthemounjaro https://twitter.com/ManOnMounjaro https://instagram.com/manonthemounjaro https://facebook.com/manonthemounjaro #Zepbound #Maritide #mounjaro 📲 Contact Me: MounjaroMan@gmail.com 👉 Link to other GLP-1 MUST HAVE products I mention: https://www.amazon.com/shop/manonthemounjaroonthepen 📼 PLAYLISTS: 🖊️ ON THE PEN LIVES: https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM 👀 WATCH MY MOUNJARO JOURNEY IN ORDER: https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO 😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS: https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW 🚨📰 ALL THE LATEST MOUNJARO NEWS: https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB Support the Show. Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message. MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Venmo: OnThePen Ca$h App: ManOnMounjaro SOCIAL LINKS https://www.tiktok.com/@manonthemounjaro https://twitter.com/ManOnMounjaro https://instagram.com/manonthemounjaro https://facebook.com/manonthemounjaro #Zepbound #Maritide #mounjaro LINKS Life Update Blog: Link: https://www.onthepen.com/post/i-m-tired-we-are-tired Wegovy released in Canada: Link: https://www.msn.com/en-ca/health/other/weight-loss-drug-wegovy-available-in-canada-starting-may-6/ar-AA1o1lZz Madison Muller at Bloomberg (friend of our community) had article "Why Weight-Loss Drugs Wegovy, Zepbound Are in Short Supply" Link: https://www.bloomberg.com/news/articles/2024-05-02/why-weight-loss-drugs-wegovy-zepbound-are-facing-shortages?srnd=undefined&embedded-checkout=true Interviewed on radio station KXEL Link: https://www.youtube.com/watch?v=V0YyMwtMuxs Optum RX Irony alert: Link: https://www.managedhealthcareexecutive.com/view/glp-1-tiering-agreement-reached-says-optum-rx-president FTC is challenging Novo Nordisk's patents on Ozempic Link: https://www.ftc.gov/system/files/ftc_gov/pdf/novo-nordisk-ozempic-saxenda-victoza-_4302024.pdf FTC requested additional information on Novo Nordisk's acquisition of Catalent: Link: https://www.msn.com/en-us/money/markets/us-ftc-seeks-more-information-on-novo-nordisk-parent-catalent-deal/ar-AA1o6gHU Support the Show. Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message. Dave Knapp does a deep dive into todays Eli Lilly earnings call. https://www.onthepen.com/post/zepbound-vial-watch-eli-lilly-earnings-q1-2024 MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Venmo: OnThePen Ca$h App: ManOnMounjaro SOCIAL LINKS https://www.tiktok.com/@manonthemounjaro https://twitter.com/ManOnMounjaro https://instagram.com/manonthemounjaro https://facebook.com/manonthemounjaro Support the Show. Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message. 1.7 mg of Wegovy is no longer in shortage: Semaglutide: FDA website updated to show 1.7 mg of Wegovy is no longer in shortage Link: https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Semaglutide%20Injection&st=c GNC introduces special section for GLP-1 users: GNC will have special section for GLP-1 users that will concentrate on four areas: GI Health, Retaining Lean muscle mass, Bone health, Nutritional support Link: https://www.gnc.com/learn/newsroom/gnc-semaglutide-support-program.html Identified upper dose values in tirzepatide high-dose trial 20 mg and 25 mg Primary Completion in this trial is 12/24/2024 (Merry Christmas) with final completion September 30, 2025 Link: https://www.onthepen.com/post/higher-doses-of-zepbound-and-mounjaro-being-tested US Senator Bernie Sanders investigating the price of Wegovy/Ozempic Ozempic costs $936 per month, while Wegovy costs $1,350 Ozempic costs $155 in Canada, and cost $59 in Germany. This dramatic difference in cost has led to concerns about the accessibility and affordability of these drugs for American patients. With the cardiovascular disease indication, millions of additional medicare patients are eligible for taking Wegovy which means billions at the current prices Link: https://www.onthepen.com/post/the-price-of-health-bernie-sanders-investigates-ozempic-and-wegovy Link: https://www.kff.org/medicare/issue-brief/a-new-use-for-wegovy-opens-the-door-to-medicare-coverage-for-millions-of-people-with-obesity/ Germany is promoting their pharmaceuticals industry: tax breaks, and speeding up clinical trials Eli Lilly is investing 2.3 Billion Euros to build a glp-1 manufacturing plant in Germany: Link: https://uk.finance.yahoo.com/news/scholz-promises-support-pharma-sector-101833297.html Lexaria begins phase 1 trial: Lexaria (stock symbol: LEXX) will test their technology to improve stomach absorption of Rybelsus in phase 1 trial (i.e. wouldn't need large 25/50 mg doses if absorption was better). They are also testing under tongue (sublingual) absorption of Rybelsus in another phase 1 trial Link: https://ir.lexariabioscience.com/news-events/press-releases/detail/246/lexaria-receives-ethics-review-board-approval-to-begin-new Viking Therapeutics earnings call Planning to start addition phase 2 trial of injectable VikingTide (VK2735) in Q4 of 2024 that will last 6-9 months (If you remember, the first phase 2 trial was only 13 weeks) The oral VikingTide (VK2735) phase 1 trial is still investigating higher and higher doses due to the low side effect profile. They expect results in summer of 2024. MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Venmo: OnThePen Ca$h App: ManOnMounjaro SOCIAL LINKS https://www.tiktok.com/@manonthemounjaro https://twitter.com/ManOnMounjaro https://instagram.com/manonthemounjaro https://facebook.com/manonthemounjaro Support the Show. Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message. New obesity medicine company launches, Lilly expands manufacturing capacity with acquisition, and TikTok censors my content. Email Alerts: https://www.onthepen.com/emails BECOME A MEMBER HERE TO WATCH THE VIDEO: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join New Obesity Medicine Company Launches: https://metsera.com/news Lilly Acquires Nexus Facility: https://finance.yahoo.com/news/lilly-buy-injectable-drug-plant-175000782.html TikTok Mounjaro Zepbound Censorship: https://www.bloomberg.com/news/articles/2024-04-22/tiktok-ozempic-influencers-say-new-rules-unfairly-target-them SOCIAL LINKS https://www.tiktok.com/@manonthemounjaro https://twitter.com/ManOnMounjaro https://instagram.com/manonthemounjaro https://facebook.com/manonthemounjaro Support the Show. Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message. Dave Knapp makes the business case for why Eli Lilly won’t simply release the vials - they have to. Email Alerts: https://www.onthepen.com/emails BECOME A MEMBER HERE TO WATCH THE VIDEO: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Bloomberg #ReleaseTheVials Feature: https://www.bloomberg.com/news/articles/2024-04-02/zepbound-shortage-patients-push-eli-lilly-to-release-more-obesity-drug-supply Yahoo Finanace #ReleaseTheVials Feature VIDEO: https://youtu.be/nQbYa47DF4Q?feature=shared #mounjaro #zepbound #tirzepatide Support the Show. Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message. This week Dave Knapp covers GLP-1 censorship on TikTok, the rise of bootleg medication scrutiny, and just how big the GLP-1 market may get in 2024. Email Alerts: https://www.onthepen.com/emails BECOME A MEMBER HERE TO WATCH THE VIDEO: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Bloomberg #ReleaseTheVials Feature: https://www.bloomberg.com/news/articles/2024-04-02/zepbound-shortage-patients-push-eli-lilly-to-release-more-obesity-drug-supply Yahoo Finanace #ReleaseTheVials Feature VIDEO: https://youtu.be/nQbYa47DF4Q?feature=shared #mounjaro #zepbound #tirzepatide Bootleg Meds: https://www.reuters.com/business/healthcare-pharmaceuticals/more-than-250-websites-selling-fake-weight-loss-drugs-reported-by-anti-2024-04-15/ Drug Shortage Reporting: https://www.wsj.com/health/healthcare/drug-medication-shortages-us-olympic-amoxicillin-107fa9d8 GLP-1 Sales: https://www.fiercepharma.com/marketing/glp-1s-track-take-drug-sales-crown-pd-1-inhibitors-2024-analyst Support the Show. Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message. 503a vs 503b pharmacies. What is the difference, and why you should care when it comes to compound tirzepatide and semaglutide. BECOME A MEMBER HERE TO WATCH THE VIDEO: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Get the whole story at: https://www.onthepen.com Bloomberg #ReleaseTheVials Feature: https://www.bloomberg.com/news/articles/2024-04-02/zepbound-shortage-patients-push-eli-lilly-to-release-more-obesity-drug-supply Yahoo Finanace #ReleaseTheVials Feature VIDEO: https://youtu.be/nQbYa47DF4Q?feature=shared #mounjaro #zepbound #tirzepatide Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life! Support the Show. Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message. Get the whole story at: https://www.onthepen.com Bloomberg #ReleaseTheVials Feature: https://www.bloomberg.com/news/articles/2024-04-02/zepbound-shortage-patients-push-eli-lilly-to-release-more-obesity-drug-supply Yahoo Finanace #ReleaseTheVials Feature VIDEO: https://youtu.be/nQbYa47DF4Q?feature=shared Yahoo Finance Catalent / Novo Deal Resubmission: https://finance.yahoo.com/news/novo-nordisk-parent-refiles-us-103118874.html Bloomberg Lilly Germany Plant: https://www.bloomberg.com/news/articles/2024-04-08/lilly-s-2-5-billion-german-plant-will-boost-obesity-drug-supply Support the Show. Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message. In the largest move since approving Tirzepatide for chronic weight management in November of 2023, the FDA has posted the approval of a single-dose vial presentation of Zepbound. With the complexity of manufacturing the current single-dose pens, single dose vial presentations could prove to be an answer to increasing manufacturing shortages of Tirzepatide for both type 2 diabetes (Mounjaro) and chronic weight management (Zepbound). The FDA approved the single-dose vials of Mounjaro in July of 2023, but Eli Lilly has elected to offer that presentation in x-US markets only. https://www.onthepen.com/post/zepbound-single-dose-vials-approved-by-fda 📲 Media Inquiries MounjaroMan@gmail.com Amazon Shop: https://www.amazon.com/shop/manonthemounjaroonthepen 📼 PLAYLISTS: 🖊️ ON THE PEN LIVES: https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM 👀 WATCH MY MOUNJARO JOURNEY IN ORDER: https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO 😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS: https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW 🚨📰 ALL THE LATEST MOUNJARO NEWS: https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB Support the Show. Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message. All things VikingTide from Viking Therapeutics VK2735 https://ir.vikingtherapeutics.com/2024-03-26-Viking-Therapeutics-Announces-Results-from-Phase-1-Clinical-Trial-of-Oral-Tablet-Formulation-of-Dual-GLP-1-GIP-Receptor-Agonist-VK2735 Amazon Remedies (affiliate links pay a commission that supports the channel): Alcohol Wipes: https://amzn.to/49WH0Kr Ginger Chews: https://amzn.to/43l6crA Tums: https://amzn.to/3vlzo59 Peppermint Tea: https://amzn.to/3VjxT20 👀 Find me everywhere + more community at: https://www.onthepen.com 🥳 Support My Work! Become a member 🙂: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join 📲 Media Inquiries MounjaroMan@gmail.com 👩 Women's Hair loss Product: https://amzn.to/3qrl3lr 👉 Link to other GLP-1 MUST HAVE products I mention: https://www.amazon.com/shop/manonthemounjaroonthepen 📼 PLAYLISTS: 🖊️ ON THE PEN LIVES: https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM 👀 WATCH MY MOUNJARO JOURNEY IN ORDER: https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO 😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS: https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW 🚨📰 ALL THE LATEST MOUNJARO NEWS: https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life! Support the Show. Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message. Amazon Remedies (affiliate links pay a commission that supports the channel): Alcohol Wipes: https://amzn.to/49WH0Kr Ginger Chews: https://amzn.to/43l6crA Tums: https://amzn.to/3vlzo59 Peppermint Tea: https://amzn.to/3VjxT20 👀 Find me everywhere + more community at: https://www.onthepen.com 🥳 Support My Work! Become a member 🙂: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join 📲 Media Inquiries MounjaroMan@gmail.com 👩 Women's Hair loss Product: https://amzn.to/3qrl3lr 👉 Link to other GLP-1 MUST HAVE products I mention: https://www.amazon.com/shop/manonthemounjaroonthepen 📼 PLAYLISTS: 🖊️ ON THE PEN LIVES: https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM 👀 WATCH MY MOUNJARO JOURNEY IN ORDER: https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO 😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS: https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW 🚨📰 ALL THE LATEST MOUNJARO NEWS: https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB Support the Show. Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message. Big news from Novo Nordisk and we have it all for you!! Cagrisema, high dose Semaglutide, new Amycretin, a triple angonist and more! 🎙️Weekly Podcast: https://podcasts.apple.com/us/podcast/on-the-pen-the-weekly-dose/id1725737068 Best away To Support Me, Become a member 🙂: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join 👉 My Amazon Storefront: https://www.amazon.com/shop/manonthemounjaroonthepen 📲 Contact Me: MounjaroMan@gmail.com 📼 PLAYLISTS: 🖊️ ON THE PEN LIVES: https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM 😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS: https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW 🚨📰 ALL THE LATEST MOUNJARO NEWS: https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB 👀 WATCH MY MOUNJARO JOURNEY IN ORDER: https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO Support the Show. Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message. This week Dave covers the latest in the Change Healthcare Hack, some interesting pubmed tirzepatide data , and Oprah’s exit from the Weight Watchers board of directors. Become a YouTube Community Member By Clicking Here: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join On The Pen Live Show (All Episodes In Order): https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM For Those Facing GLP-1 Access Issues: Https://www.FlexFinance.Care Tell them “Dave sent you” 😉 Zepbound FB Group: https://www.facebook.com/share/oxMJXxuLTwczPpWq/?mibextid=K35XfP SHOW LINKS Change Healthcare Ransom Paid: https://www.wired.com/story/alphv-change-healthcare-ransomware-payment/ Pubmed Asians vs. Non-Asians With DM2 Using Tirzepatide https://pubmed.ncbi.nlm.nih.gov/38402331/ Oprah Leaving WW Board https://www.thedailybeast.com/oprah-is-leaving-weightwatchers-after-revealing-weight-loss-drug-use Dr. Michael Albert Interview: https://youtu.be/nB9CXEsGNDc The Big Shot Review https://youtu.be/l-uyFOxqSYk Support the Show. Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message. Dave Knapp (@ManOnTheMounjaro) joins Dr. Michael Albert, a leading voice in the obesity medicine, for a gripping conversation on the current and future state of obesity medicine. Become a Community Member By Clicking Here: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join On The Pen Live Show (All Episodes In Order): https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM For Those Facing GLP-1 Access Issues: Https://www.FlexFinance.Care Tell them “Dave sent you” 😉 Zepbound FB Group: https://www.facebook.com/share/oxMJXxuLTwczPpWq/?mibextid=K35XfP Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message. This week we cover: - New readouts on the new Boehringer Ingleheim investigational med Survodutide. - Wegovy launches in Japan, and the - Change Healthcare cyber attack and how it’s effecting your prescription refills Become a Community Member By Clicking Here: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join On The Pen Live Show (All Episodes In Order): https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM For Those Facing GLP-1 Access Issues: Https://www.FlexFinance.Care Tell them “Dave sent you” 😉 Zepbound FB Group: https://www.facebook.com/share/oxMJXxuLTwczPpWq/?mibextid=K35XfP SHOW LINKS Survodutide Top Line Data: https://www.biospace.com/article/boehringer-s-obesity-candidate-shows-strong-potential-in-mash/ Wegovy in Japan: https://www3.nhk.or.jp/nhkworld/en/news/20240222_34/ Change Healthcare Hack: https://www.fastcompany.com/91037949/change-healthcare-cyber-attack-update-pharmacies-big-deal Support the Show. Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message. Become a Community Member By Clicking Here: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join On The Pen Live Show (All Episodes In Order): https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM For Those Facing GLP-1 Access Issues: Https://www.FlexFinance.Care Tell them “Dave sent you” 😉 Zepbound FB Group: https://www.facebook.com/share/oxMJXxuLTwczPpWq/?mibextid=K35XfP SHOW LINKS Number of people on glp-1 https://www.tipranks.com/news/weight-loss-drugs-are-slimming-down-grocery-bills Morgan Stanley Sees Lilly as first 1T pharma stock https://www.cnbc.com/2024/02/16/zepbound-could-propel-eli-lilly-to-become-the-first-1-trillion-pharma-stock.html EU Kwik Pen Approval https://www.reuters.com/business/healthcare-pharmaceuticals/eu-drug-regulator-review-lillys-mounjaro-multi-dose-pen-2024-02-19/ Gastric Bypass and T2D https://www.medicalnewstoday.com/articles/how-gastric-bypass-surgery-can-help-with-type-2-diabetes-remission Unfilled GLP-1 Scripts: https://www.iqvia.com/locations/united-states/blogs/2023/08/new-demand-in-an-old-market Support the Show. Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message. Dive deep into the Novo Nordisk and Catalent merger and how that will affect the GLP-1 market. 🙏 Become a Channel Member By Clicking Here: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join On The Pen Live Show (All Episodes In Order): https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM For Those Facing GLP-1 Access Issues: Https://www.FlexFinance.Care Tell them “Dave sent you” 😉 Zepbound FB Group: https://www.facebook.com/share/oxMJXxuLTwczPpWq/?mibextid=K35XfP Thank you for watching my GLP-1 videos! If you found this content valuable, make sure to like, share, and subscribe to my channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life! Support the Show. Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message. Man on the Mounjaro Dave Knapp recxaps the 2023 Q4 ELi Lilly Earnings Call as it relates to obesity medicine. Link To Earnings Call: https://investor.lilly.com/webcasts-and-presentations 🙏 Become a Channel Member By Clicking Here: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join On The Pen Live Show (All Episodes In Order): https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM For Those Facing GLP-1 Access Issues: Https://www.FlexFinance.Care Tell them “Dave sent you” 😉 Zepbound FB Group: https://www.facebook.com/share/oxMJXxuLTwczPpWq/?mibextid=K35XfP Thank you for watching my GLP-1 videos! If you found this content valuable, make sure to like, share, and subscribe to my channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life! Support the Show. Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message. 🙏 Become a Channel Member By Clicking Here: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join On The Pen Live Show (All Episodes In Order): https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM For Those Facing GLP-1 Access Issues: Https://www.FlexFinance.Care Tell them “Dave sent you” 😉 Zepbound FB Group: https://www.facebook.com/share/oxMJXxuLTwczPpWq/?mibextid=K35XfP News Links: https://www.statnews.com/2024/02/05/amgen-obesity-drug-maintenance/ https://www.marketwatch.com/story/novo-nordisks-controlling-shareholder-to-buy-catalent-for-16-5-billion-7d57fcfc https://www.reuters.com/business/healthcare-pharmaceuticals/abbott-launches-protein-shake-brand-help-people-weight-loss-drug-2024-01-31/?fbclid=IwAR3Zo6H3oFlv64aey7pOVQ-b25HoUeFBifBmuEkIjBVyEVN9hQB-aSr9o50_aem_AUWiG99wtAtBGejL31bUvjTvF0rBp16fchnVdcRcAgUVf5uHgLByYRhedO9eJrxbHe4 Support the Show. Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!